| 摘要 |
The present invention relates to new uses of PSK-I in the diagnosis, screening, treatment and prophylaxis of ovarian and lung cancer. The invention also provides compositions comprising PSK-I, including vaccines, antibodies that are immunospecific for PSK-I and agents which interact with or modulate the expression or activity of PSK-I or which modulate the expression of the nucleic acid which codes for PSK-I . |
